Table 4.
n | B | 95 % CI for B | p value | |
---|---|---|---|---|
Gastrointestinal | ||||
No | 13 | Ref | ||
Yes | 28 | 0.02 | −1.04; 1.08 | 0.97 |
Dermatologicala | ||||
No | 4 | Ref | ||
Yes | 37 | 0.41 | −1.86; 2.68 | 0.72 |
Oral | ||||
No | 9 | Ref | ||
Yes | 32 | 0.41 | −0.98; 1.80 | 0.57 |
Upper respiratory | ||||
No | 25 | Ref | ||
Yes | 16 | 0.29 | −0.88; 1.44 | 0.62 |
Lower respiratorya | ||||
No | 2 | Ref | ||
Yes | 39 | 0.67 | −1.37; 2.70 | 0.51 |
Cardiovascular | ||||
No | 30 | Ref | ||
Yes | 11 | 0.29 | −0.88; 1.45 | 0.62 |
History of anaphylaxis | ||||
No | 18 | Ref | ||
Yes | 23 | −0.33 | −1.23; 0.58 | 0.46 |
Adjusted for the covariates: sex, number of symptoms, history of anaphylaxis, adrenaline auto injector prescription and concomitant allergic disease, excluding predictor
Non-mutually exclusive symptoms
a Interpret with caution due to small counts